Pregnant and lactating people’s strategies to mitigate the risk of cannabis consumption
Abstract Background: Multiple studies have demonstrated that pregnant and lactating people who use cannabis perceive a variety of benefits from…
Abstract Background: Multiple studies have demonstrated that pregnant and lactating people who use cannabis perceive a variety of benefits from…
Abstract Aim: This Norwegian case study examines groups at risk of drug overdose deaths, evidence-based harm reduction interventions, low-threshold services…
Abstract Background: Emerging adults have the highest cannabis consumption rates in Canada and are among the most vulnerable to cannabis-related…
Abstract Background: Cannabis use before the COVID-19 pandemic for many involved sharing prepared cannabis for inhalation, practices that were less…
Abstract Background: The 2018 legalisation of cannabis in Canada sparked concern and conversation about the potential negative impacts of youth…
Abstract Objective: The drug poisoning crisis throughout North America necessitates novel harm reduction approaches. Emerging evidence suggests that cannabidiol (CBD)…
Abstract Background: Lower-risk substance use guidelines (LRSUGs) are an evidence-based harm reduction strategy used to provide information to people who…
Abstract Significance: Electronic cigarettes (e-cigarettes) aerosolise liquids that contain nicotine, propylene glycol, glycerol and appealing flavours. In the USA, regulations…
Abstract With rising numbers of drug-related deaths in the UK and globally, exploration of interventions that seek to reduce drug-related…
Abstract Introduction: Cannabidiol (CBD), the second most prevalent cannabinoid found in cannabis, is considered to be safe for use. Studies…